Pfizer Expands OXECTA Commercialization Plans

Pfizer Inc. (NYSE: PFE) will expand commercialization plans for its abuse deterrent OXECTA Tablets CII that use Acura Pharmaceuticals Inc.'s (Nasdaq: ACUR) AVERSION Technology. Pfizer stock edged up 7 cents to $28.08 while Acura stock soared 38 cents to $2.26.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here